PL1660633T3 - Zamknięte komórki macierzyste i ich zastosowania - Google Patents

Zamknięte komórki macierzyste i ich zastosowania

Info

Publication number
PL1660633T3
PL1660633T3 PL04780535T PL04780535T PL1660633T3 PL 1660633 T3 PL1660633 T3 PL 1660633T3 PL 04780535 T PL04780535 T PL 04780535T PL 04780535 T PL04780535 T PL 04780535T PL 1660633 T3 PL1660633 T3 PL 1660633T3
Authority
PL
Poland
Prior art keywords
stem cells
entrapped stem
entrapped
cells
stem
Prior art date
Application number
PL04780535T
Other languages
English (en)
Inventor
Bryan Conn
Albert L Rubin
Kurt Stenzel
Barry Smith
Original Assignee
The Rogosin Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Rogosin Inst filed Critical The Rogosin Inst
Publication of PL1660633T3 publication Critical patent/PL1660633T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0693—Tumour cells; Cancer cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02—Preservation of living parts
    • A01N1/0205—Chemical aspects
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02—Preservation of living parts
    • A01N1/0205—Chemical aspects
    • A01N1/0231—Chemically defined matrices, e.g. alginate gels, for immobilising, holding or storing cells, tissue or organs for preservation purposes; Chemically altering or fixing cells, tissue or organs, e.g. by cross-linking, for preservation purposes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/13—Tumour cells, irrespective of tissue of origin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/54—Ovaries; Ova; Ovules; Embryos; Foetal cells; Germ cells
    • A61K35/545—Embryonic stem cells; Pluripotent stem cells; Induced pluripotent stem cells; Uncharacterised stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0012—Cell encapsulation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • C12N5/0606—Pluripotent embryonic cells, e.g. embryonic stem cells [ES]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/02—Coculture with; Conditioned medium produced by embryonic cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/70—Polysaccharides
    • C12N2533/76—Agarose, agar-agar

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Reproductive Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Epidemiology (AREA)
  • Environmental Sciences (AREA)
  • Dentistry (AREA)
  • Immunology (AREA)
  • Dispersion Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
PL04780535T 2003-09-04 2004-08-09 Zamknięte komórki macierzyste i ich zastosowania PL1660633T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10/655,275 US20050053586A1 (en) 2003-09-04 2003-09-04 Entrapped stem cells and uses thereof
PCT/US2004/025713 WO2005026320A2 (en) 2003-09-04 2004-08-09 Entrapped stem cells and uses thereof
EP20040780535 EP1660633B9 (en) 2003-09-04 2004-08-09 Entrapped stem cells and uses thereof

Publications (1)

Publication Number Publication Date
PL1660633T3 true PL1660633T3 (pl) 2015-08-31

Family

ID=34226098

Family Applications (1)

Application Number Title Priority Date Filing Date
PL04780535T PL1660633T3 (pl) 2003-09-04 2004-08-09 Zamknięte komórki macierzyste i ich zastosowania

Country Status (17)

Country Link
US (4) US20050053586A1 (pl)
EP (1) EP1660633B9 (pl)
JP (1) JP5069466B2 (pl)
KR (1) KR101294417B1 (pl)
CN (1) CN101415817B (pl)
AU (1) AU2004272987C1 (pl)
CA (1) CA2537861C (pl)
DK (1) DK1660633T3 (pl)
ES (1) ES2537755T3 (pl)
HK (1) HK1126815A1 (pl)
IL (1) IL173342A (pl)
NO (1) NO338248B1 (pl)
NZ (2) NZ545542A (pl)
PL (1) PL1660633T3 (pl)
PT (1) PT1660633E (pl)
RU (1) RU2346040C2 (pl)
WO (1) WO2005026320A2 (pl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG131016A1 (en) 2005-09-19 2007-04-26 Millipore Corp Asymmetric porous adsorptive bead
WO2008157324A2 (en) * 2007-06-13 2008-12-24 Fmc Corporation Peptide linked cell matrix materials for stem cells and methods of using the same
JP2012527868A (ja) * 2009-05-27 2012-11-12 バイエル・マテリアルサイエンス・アクチェンゲゼルシャフト 被覆細胞培養担体の製造方法
CA2801370C (en) * 2010-11-23 2018-03-06 The Rogosin Institute, Inc. Method for isolating a chemotherapeutic agent resistant cancer cell with stem cell properties
US10655120B2 (en) 2011-03-21 2020-05-19 The University Of Newcastle Upon Tyne Transport of cells in hydrogels
HUE034618T2 (en) * 2012-01-31 2018-02-28 The Rogosin Inst Inc An improved process for producing macros

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US38027A (en) 1863-03-31 Improved method of affixing tubes in steam-condensers
US4352883A (en) 1979-03-28 1982-10-05 Damon Corporation Encapsulation of biological material
US4409331A (en) 1979-03-28 1983-10-11 Damon Corporation Preparation of substances with encapsulated cells
DE3032931C2 (de) 1980-09-02 1982-07-29 Robert Bürkle GmbH & Co, 7290 Freudenstadt Verfahren und Anordnung zur Herstellung von Mehrschicht-Leiterplatten
SE441009B (sv) 1982-03-08 1985-09-02 Kjell Nilsson Sett att immobilisera levande biomaterial i perlformiga polymerer
US4798786A (en) 1982-05-06 1989-01-17 Stolle Research And Development Corporation Living cells encapsulated in crosslinked protein
CA1196862A (en) 1983-06-01 1985-11-19 Anthony M.F. Sun Microencapsulation of living tissue and cells
US4663286A (en) 1984-02-13 1987-05-05 Damon Biotech, Inc. Encapsulation of materials
US4997443A (en) 1985-08-26 1991-03-05 Hana Biologics, Inc. Transplantable artificial tissue and process
US4902295A (en) 1985-08-26 1990-02-20 Hana Biologics, Inc. Transplantable artificial tissue
SE8604684L (sv) 1986-11-03 1988-05-04 Excorim Kommanditbolag Sett att belegga fasta partiklar med en hydrofil gel samt genom settet belagda partiklar
US5053332A (en) 1989-07-24 1991-10-01 Cook Richard B Agarose beads, preferably incorporating biological materials
US5227298A (en) 1990-08-17 1993-07-13 The Trustees Of Columbia University In The City Of New York Method for microencapuslation of cells or tissue
ES2260568T3 (es) 1994-01-13 2006-11-01 The Rogosin Institute Celulas secretoras macroencapsuladas.
US6303151B1 (en) * 1996-04-03 2001-10-16 The Rogosin Institute Cancer-cell proliferation-suppressing material produced by cancer cells restricted by entrapment
US6224912B1 (en) * 1996-04-03 2001-05-01 The Rogo Institute Cancer-cell proliferation-suppressing material produced by cancer cells restricted by entrapment
US5888497A (en) 1996-04-03 1999-03-30 The Rogosin Institute Agarose coated agarose beads containing cancer cells that produce material which suppresses cancer cell proliferation
DE60230593D1 (de) * 2001-02-06 2009-02-12 Massachusetts Inst Technology Peptidgerüstverkapselung von gewebszellen und verwendungen davon
CA2351156A1 (en) * 2001-07-04 2003-01-04 Peter W. Zandstra A bioprocess for the generation of pluripotent cell derived cells and tissues
JP2004248505A (ja) * 2001-09-21 2004-09-09 Norio Nakatsuji 移植抗原の一部または全てを欠除したｅｓ細胞由来の未分化な体細胞融合細胞およびその製造
US20050130144A1 (en) * 2001-09-21 2005-06-16 Norio Nakatsuji Method of screening reprogramming factor, reprogramming factor screened by the method, method of using the reprogramming factor, method of differentiating undifferentiated fused cells and method of constructing cell, tissues and organs
JP4317337B2 (ja) * 2001-10-16 2009-08-19 株式会社リプロセル 細胞株継代用酵素溶液、および、それを用いた霊長類胚性幹細胞の培養増殖方法
US7101546B2 (en) * 2001-12-21 2006-09-05 Amcyte, Inc. In situ maturation of cultured pancreatic stem cells having a specified, intermediate stage of development
KR101386690B1 (ko) * 2004-03-04 2014-04-22 도쿠리츠교세이호진 고쿠리츠간켄큐센터 래트 배아 줄기 세포

Also Published As

Publication number Publication date
NZ545542A (en) 2010-01-29
NO338248B1 (no) 2016-08-08
JP2007513057A (ja) 2007-05-24
ES2537755T3 (es) 2015-06-11
US20050053586A1 (en) 2005-03-10
DK1660633T3 (en) 2015-05-04
RU2006110637A (ru) 2007-10-10
KR20060123704A (ko) 2006-12-04
AU2004272987C1 (en) 2008-04-03
JP5069466B2 (ja) 2012-11-07
US20060216278A1 (en) 2006-09-28
CA2537861A1 (en) 2005-03-24
IL173342A0 (en) 2006-06-11
NZ577865A (en) 2010-04-30
HK1126815A1 (en) 2009-09-11
EP1660633B9 (en) 2015-05-06
CN101415817B (zh) 2014-08-06
WO2005026320A3 (en) 2009-04-09
EP1660633A2 (en) 2006-05-31
US7838291B2 (en) 2010-11-23
EP1660633B1 (en) 2015-03-04
RU2346040C2 (ru) 2009-02-10
CN101415817A (zh) 2009-04-22
WO2005026320A2 (en) 2005-03-24
AU2004272987A1 (en) 2005-03-24
US20080020463A1 (en) 2008-01-24
IL173342A (en) 2013-11-28
AU2004272987B2 (en) 2007-09-06
US20110275155A1 (en) 2011-11-10
PT1660633E (pt) 2016-01-18
KR101294417B1 (ko) 2013-08-08
CA2537861C (en) 2012-04-10
NO20061478L (no) 2006-06-02
EP1660633A4 (en) 2009-12-02

Similar Documents

Publication Publication Date Title
EP1689854A4 (en) PLACENTAR STEM CELLS AND USES THEREOF
GB0329449D0 (en) Stem cells
ZA200603882B (en) Substituted benzimidazole-, benztriazole-, and benzimidazolone-O-glucosides
IL175491A0 (en) Substituted benzimidazole-, benztriazole-, and benzimidazolone-o-glucosides
GB2427616B (en) Stem cells
AU2003247514A8 (en) Meningeal-derived stem cells
EP1664746A4 (en) ANTIOXIDANT SENSOR, METHODS AND COMPOSITIONS THEREFOR
TWI316092B (en) Alloy and its use
HK1088837A1 (en) Clk-peptide and slk-peptide
IL179497A0 (en) Carboranylporphyrins and uses thereof
EP1699485A4 (en) ANTI-HYDROLYSATE ANTIBODIES AND ITS USES
AU2003224702A8 (en) Stem cell selection and differentiation
HK1126815A1 (en) Entrapped stem cells and uses thereof
GB0315846D0 (en) Solar cells and encapsulation thereof
GB0428391D0 (en) Connection and connection part
IL180365A0 (en) Carboranylporphyrins and uses thereof
IL172510A0 (en) Antibodies and uses thereof
EP1581637A4 (en) MATERIALS AND METHODS WITH HUMAN STEM CELLS
GB0206357D0 (en) Cells
AU157289S (en) Battery
EP1685237A4 (en) NEW MULTIPOTENT STEM CELLS
GB0425172D0 (en) Plant cells and uses thereof
GB0318546D0 (en) Quinoxalinones and their use
TW572368U (en) Stackable battery and stackable battery assembly
EP1660088A4 (en) PYRIDOMORPHINANES, PYRIDAZINOMORPHINANES AND USE THEREOF